93812 people have viewed this drug in the last 60 days
| Name | Price | Visits | Updated |
|---|---|---|---|
| MONOVISC | $463.15 | 204205 visits | 2022-08-01 |
| Cellular Matrix BCT-HA Kit | $998.2 | 242084 visits | 2022-12-01 |
| Curavisc | $144.65 | 183162 visits | 2022-08-29 |
| Ribolisin | $33.9 | 278218 visits | 2022-11-27 |
| Hyalfid | $42 | 68431 visits | 2023-03-20 |
| Hyalfid Gel | $42 | 207628 visits | 2023-03-20 |
| AVIZOR LACRIFRESH OCU DRY 0.3% | $46.1 | 56668 visits | 2022-08-29 |
| Hyacorp Fine | $273.888 | 190180 visits | 2022-11-30 |
| Hyalax Light | $320.95 | 297592 visits | 2022-08-29 |
| Vislube EYD DROPS | $28.4 | 76279 visits | 2022-08-29 |
| VISMED MULTI EYE DROPS | $30.75 | 120969 visits | 2023-02-20 |
| RIBOLISIN EYE DROPS | $33.9 | 111016 visits | 2022-11-27 |
| SUPLASYN 1-SHOT INJECTION | $478.05 | 52361 visits | 2022-08-29 |
| Hyalo4 Plus | $45.001 | 30195 visits | 2022-11-29 |
| SUPLASYN 20MG/2ML INJECTION | $144.65 | 93812 visits | 2022-08-29 |
| Pluryal CLASSIC | $301.928 | 193061 visits | 2022-08-29 |
| Pluryal VOLUME | $352.25 | 224497 visits | 2022-08-29 |
| Pluryal BOOSTER | $286.832 | 66886 visits | 2022-11-29 |
| Vislube GEL | $46.1 | 231613 visits | 2022-08-29 |
| VIZOL 0.21% EYE DROPS | $41 | 76208 visits | 2022-08-29 |
| ARTELAC SPLASH 0.24% EYE DROP | $41 | 87185 visits | 2022-08-29 |
| VIZOL 0.4% EYE DROPS | $41 | 73046 visits | 2022-08-29 |
| HYFRESH EYE GEL UD | $46.1 | 19603 visits | 2023-02-15 |
| Z FILL REFRESH 2 IMPLANT IN PRE-FILLED S | $251.15 | 110194 visits | 2022-08-29 |
| Z FILL CONTOUR 2 IMPLANT IN PRE-FILLED S | $320.95 | 209658 visits | 2022-08-29 |
| Z FILL DEEP 2 IMPLANT IN PRE-FILLED SYRI | $320.95 | 183560 visits | 2022-08-29 |
| BIOSOFT PLUS EYE DROP | $31.1 | 184334 visits | 2022-11-29 |
| BIOSOFT EYE DROP | $31.1 | 85106 visits | 2022-08-29 |
| HYALGAN 20MG-2ML PRE-FILLED SYRINGE | $144.65 | 95761 visits | 2022-08-29 |
| HYLO-COMOD 0.1% EYE DROP | $43.15 | 158813 visits | 2022-08-29 |
| ORTHOVISC 15MG-ML SOLU FOR I-A Injection | $249.55 | 15337 visits | 2022-08-29 |